The ubiquitin-proteasome pathway in cancer.
Degradation by the 26S proteasome of specific proteins that have been targeted by the ubiquitin pathway is the major intracellular non-lysosomal proteolytic mechanism and is involved in a broad range of processes, such as cell cycle progression, antigen presentation and control of gene expression. R...
Main Authors: | Spataro, V, Norbury, C, Harris, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1998
|
Similar Items
-
Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
by: Ernst, Robert, et al.
Published: (2011) -
Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity.
by: Wang, E, et al.
Published: (2000) -
The ubiquitin-proteasome pathway is dysregulated in myeloma cells in the bone microenvironment in vivo
by: Edwards, C, et al.
Published: (2007) -
The Major Histocompatibility Complex (MHC) and the proteasome-ubiquitin pathway in T cell development
by: Vugmeyster, Yulia, 1973-
Published: (2005) -
Role of the ubiquitin-proteasome pathway in the inner ear : identification of an E3 ubiquitin ligase for Atoh1
by: Cheng, Yen-Fu
Published: (2015)